Metabolic syndrome (MetS) refers to a cluster of metabolic dysregulations, which include
insulin resistance, obesity, atherogenic dyslipidemia and hypertension. The complex …

The introduction of potent combination antiretroviral therapy (cART) has had a remarkable
impact on the natural history of HIV infection, leading to a dramatic decline in the mortality …

Background The associations of the apolipoprotein B gene (APOB) rs693 and rs17240441
polymorphisms with plasma levels of APOB and lipids have been widely explored, but the …

The prognosis of human immunodeficiency virus (HIV)-infected individuals has dramatically
improved worldwide since the introduction of highly antiretroviral therapy. Nevertheless …

Background Dyslipidemia is recognized as one of the risk factors of cardiovascular diseases
(CVDs), type 2 diabetes mellitus (T2DM), and non‐alcoholic fatty liver disease (NAFLD) …

Objective This study evaluated the impact of seven single nucleotide polymorphisms in five
candidate genes (ABCB1, ABCC2, ABCC4, SLC22A6, and SLC22A11) in relation to …

After the introduction of highly active antiretroviral therapy in the 1990s, the perception of the
diagnosis of HIV infection gradually shifted from a 'death sentence'to a chronic disease …

HIV-infected individuals on chronic use of highly active antiretroviral therapy (HAART) are
more likely to develop adipose tissue and metabolic disorders, such as lipodystrophy (LD) …

Dyslipidemia is a potential complication of long-term usage of antiretroviral therapy (ART)
and also known to be associated with genetic factors. The host genetic variants associated …

Background: Dyslipidemia does not occur in all HIV-infected or antiretroviral therapy-
experienced patients suggesting role of host genetic factors but there is paucity of data on …